Sumant Kulkarni
Stock Analyst at Canaccord Genuity
(0)
# 4691
Out of 5,368 analysts
128
Total ratings
28.00%
Success rate
-16.07%
Average return
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ANVS Annovis Bio | Maintains: Buy | 26 17 | 2.83 | 500.71% | 3 | May 15, 2025 | |
NBIX Neurocrine Bioscienc... | Maintains: Strong Buy | 158 160 | 124.45 | 28.57% | 16 | May 6, 2025 | |
BIIB Biogen | Maintains: Buy | 265 220 | 130.62 | 68.43% | 16 | May 2, 2025 | |
CRVO CervoMed | Maintains: Strong Buy | 12 21 | 7.09 | 196.19% | 5 | Mar 18, 2025 | |
ZVRA Zevra Therapeutics | Maintains: Strong Buy | 23 25 | 9.11 | 174.42% | 6 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 14 12 | 3.29 | 264.74% | 5 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 23 15 | 4.4 | 240.91% | 3 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 9 8 | 6.71 | 19.23% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 86 73 | 8.35 | 774.25% | 7 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 119 132 | n/a | n/a | 5 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 112 80 | 1.54 | 5094.81% | 7 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 31 28 | 12.64 | 121.52% | 4 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 11 11 | 2.12 | 418.87% | 1 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 86 83 | 4.11 | 1919.46% | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 16 14 | 7.16 | 95.53% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 360 36 | n/a | n/a | 4 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 20 | 11.54 | 73.31% | 3 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 40 33 | 21.68 | 52.21% | 13 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 2 | n/a | n/a | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 4 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 101 150 | 15.47 | 869.62% | 4 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 20 | n/a | n/a | 4 | Sep 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 110 120 | n/a | n/a | 2 | Feb 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 2 | Jan 31, 2017 |